Screener
LB Pharmaceuticals Inc LBRX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating lease liabilities | (99) | 2 |
| Accrued interest on marketable securities | 103 | 40 |
| Accounts payable and accrued expenses | 3,464 | (2,894) |
| Net cash used in operating activities | (23,290) | (8,128) |
| Investing Activities | ||
| Purchases of property and equipment | (32) | (21) |
| Proceeds from the sale of marketable securities | — | 2,501 |
| Maturities of marketable securities | — | 2,500 |
Item 1. Financial Statements
FAQ
- What is LB Pharmaceuticals Inc's operating cash flow?
- LB Pharmaceuticals Inc (LBRX) reported operating cash flow of -$23.29M in Q1 2026.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about LB Pharmaceuticals Inc's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude